Malignant mesothelioma treated with immune checkpoint inhibitors with or without cancer vaccine (the NIPU-study)
![](https://www.ous-research.no/helland/images/NIPU-ikon.png)
– a phase II randomised clinical and translational trial
- EudraCT number: 2019-002721-30
- Clinicaltrials.gov: NCT04300244
Background/study objectives |
Study design |
Collaborative partners |
Update/publications |